Comparing the effectiveness of Carbetocin and Oxytocin in preventing postpartum hemorrhage in preeclampsia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20241030008

Enrollment

520

Registered

2024-10-30

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia,pregnancy Preeclampsia,Postpartum Hemorrhage,Carbetocin,Oxytocin

Interventions

100 micrograms diluted in 100 milliliters of 0.9% normal saline solution (NSS), administered intravenously.,A dosage of 10-20 IU diluted in 100 milliliters of 0.9% normal saline solution (NSS), admini

Prevention,Prevention

carbetocin,oxytocin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1 Pregnant women with preeclampsia 2 who received Carbetocin or Oxytocin for the prevention of postpartum hemorrhage. 3 receiving antenatal care and delivering at Samut Prakan Hospital from January 1, 2020, to July 31, 2024.

Exclusion criteria

Exclusion criteria: 1 Incomplete data 2 twin pregnancy 3 placenta previa 4 anemia

Design outcomes

Primary

Measure	Time frame
Blood loss during Labor ml	—

Secondary

Measure	Time frame
complicatiom after labor yes/no	—

Countries

Thailand

Contacts

Public ContactLalita Songsathaporn

Obstetric and gynecology department,Samut Prakan hospital

Lookpearlalita@gmail.com0910195668

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026